Elutia company info

What does Elutia do?
Elutia (NASDAQ:ELUT) is a commercial-stage company focused on developing and selling drug-eluting biomatrix products in the United States. These products combine biocompatible materials with medications to improve how medical devices interact with the body. Elutia's target markets include neurostimulation, wound care, and breast reconstruction. By enhancing compatibility, they aim to reduce complications and improve patient outcomes. The company is still growing, and anticipates a regulatory decision for its CanGarooRM product in the first half of 2024.
Elutia company media
Company Snapshot

Is Elutia a public or private company?

key
Ownership
Public

How many people does Elutia employ?

people
Employees
54

What sector is Elutia in?

pie chart
Sector
Health Care

Where is the head office for Elutia?

location pin
Head Office
Silver Spring, United States

What year was Elutia founded?

founded flag
Year Founded
2015
What does Elutia specialise in?
/Regenerative Medicine /Biologic Products /Tissue Preservation /ProxiCor Technology /CanGaroo Envelope /Silver-Plated Products

What are the products and/or services of Elutia?

Overview of Elutia offerings
CanGaroo - This line of products is designed for use with cardiac implantable electronic devices (CIED) like pacemakers and defibrillators.
SimpliDerm - This product line uses human acellular dermal matrix (hADM) for tissue repair and reconstruction in various applications.
CanGaroo RM - which adds the powerful antibiotics rifampin and minocycline for sustained delivery directly to the surgical site.
Device Protection: Elutia's CanGaroo product line uses a proprietary drug-eluting biomaterial platform to coat implantable electronic devices. This coating helps to reduce scar tissue formation and infections around the implant, which can lead to device failure and other complications.
Women's Health: Elutia's SimpliDerm product line uses the same drug-eluting biomaterial platform to create a patch that can be used to repair damaged soft tissue. This product is designed to be used in a variety of procedures, including breast reconstruction and hernia repair.

Who is in the executive team of Elutia?

Elutia leadership team
  • Mr. Kevin L. Rakin M.B.A, M.S.
    Mr. Kevin L. Rakin M.B.A, M.S.
    Executive Chairman
  • Dr. C. Randal Mills Ph.D.
    Dr. C. Randal Mills Ph.D.
    Co-Founder, President & CEO and Director
  • Mr. Matthew B. Ferguson
    Mr. Matthew B. Ferguson
    Chief Financial Officer
  • Ms. Erica  Elchin
    Ms. Erica Elchin
    Vice President of Global Operations
  • Dr. Michelle LeRoux Williams Ph.D.
    Dr. Michelle LeRoux Williams Ph.D.
    Chief Scientific Officer
  • Ms. Courtney  Guyer
    Ms. Courtney Guyer
    Vice President of Marketing
  • Dr. Sonali  Fonseca Ph.D.
    Dr. Sonali Fonseca Ph.D.
    VP & Head of Emerging Businesses
  • Mr. Jeffry D. Hamet
    Mr. Jeffry D. Hamet
    Senior VP of Finance, Treasurer & Secretary